|
Ruiz-Roca JA, Pons-Fuster E, Lopez-Jornet P. Effectiveness of the Botulinum Toxin for Treating Sialorrhea in Patients with Parkinson's Disease: A Systematic Review. J Clin Med. 2019 Mar 6;8(3):317. doi: 10.3390/jcm8030317. PubMed PMID: 30845700; PubMed Central PMCID: PMC6463012.
AÑO: 2019; IF: 3.303
|
30845700
|
Pons-Fuster Lopez E, Gomez Garcia F, Lopez Jornet P. Combination of 5-Florouracil and polyphenol EGCG exerts suppressive effects on oral cancer cells exposed to radiation. Arch Oral Biol. 2019 May;101:8-12. doi: 10.1016/j.archoralbio.2019.02.018. Epub 2019 Feb 28. PubMed PMID: 30851692.
AÑO: 2019; IF: 1.931
|
|
Salehi B, Lopez-Jornet P, Pons-Fuster Lopez E, Calina D, Sharifi-Rad M, Ramirez-Alarcon K, Forman K, Fernandez M, Martorell M, Setzer WN, Martins N, Rodrigues CF, Sharifi-Rad J. Plant-Derived Bioactives in Oral Mucosal Lesions: A Key Emphasis to Curcumin, Lycopene, Chamomile, Aloe vera, Green Tea and Coffee Properties. Biomolecules. 2019 Mar 17;9(3):106. doi: 10.3390/biom9030106. PubMed PMID: 30884918; PubMed Central PMCID: PMC6468600.
AÑO: 2019; IF: 4.082
|
|
Salmeron D, Gomez Garcia F, Pons-Fuster E, Perez-Sayans M, Lorenzo-Pouso AI, Lopez-Jornet P. Screening for prediabetes and risk of periodontal disease. Diabetes Metab Syndr. 2019 Mar-Apr;13(2):1661-1666. doi: 10.1016/j.dsx.2019.03.006. Epub 2019 Mar 12. PubMed PMID: 31336538.
AÑO: 2019
|
|
Pons-Fuster López E, Seoane Leston J, López Jornet P. Epigallocatechin-3-gallate reduces damage to osteoblast-like cells treated with Zoledronic acid. Arch Oral Biol. 2018 Oct;94:27-32. doi: 10.1016/j.archoralbio.2018.06.018. Epub 2018 Jun 20. PubMed PMID: 29945092.
AÑO: 2018; IF: 1.663
|